Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

Samankaltaisia teoksia

• The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
  Tekijä: Burnett, A, et al.
  Julkaistu: (2002)
• A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
  Tekijä: Wheatley, K, et al.
  Julkaistu: (1995)
• Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.
  Tekijä: Watson, M, et al.
  Julkaistu: (1999)
• Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
  Tekijä: Goh, Chermaine Yu Zhen
  Julkaistu: (2021)
• The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
  Tekijä: Grimwade, D, et al.
  Julkaistu: (2001)